Position in XERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,077,060
+$7,170,148 QoQ
Shares Held
1,909,838
-23.7% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ARMISTICE CAPITAL, LLC holds $281,938,279 across 8 Drug Manufacturers - Specialty & Generic names. XERS ranks #4 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,895,347 | $97,970,486 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
724,000 | $95,379,760 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
15,028,000 | $52,748,280 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
1,909,838 | $11,077,060 | |
| 5 | ESPR |
Esperion Therapeutics, Inc.
|
3,930,125 | $10,768,542 | |
| 6 | EOLS |
Evolus, Inc.
|
1,396,000 | $5,737,560 | |
| 7 | CTOR |
Citius Oncology, Inc.
|
9,188,855 | $5,697,090 | |
| 8 | BTAI |
BioXcel Therapeutics, Inc.
|
1,910,076 | $2,559,501 |
All Filings in XERS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,077,060 | 1,909,838 | Shares | Sole | 2026-05-15 | |
| 2022-09-30 | $3,906,912 | 2,504,431 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,968,960 | 5,824,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $19,110,382 | 7,464,993 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||